Macquarie Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,683
| Closed | -$290K | – | 2678 |
|
2021
Q3 | $290K | Hold |
1,683
| – | – | ﹤0.01% | 1747 |
|
2021
Q2 | $211K | Hold |
1,683
| – | – | ﹤0.01% | 1795 |
|
2021
Q1 | $228K | Sell |
1,683
-468
| -22% | -$63.4K | ﹤0.01% | 1674 |
|
2020
Q4 | $275K | Buy |
2,151
+900
| +72% | +$115K | ﹤0.01% | 1582 |
|
2020
Q3 | $141K | Sell |
1,251
-534
| -30% | -$60.2K | ﹤0.01% | 1696 |
|
2020
Q2 | $170K | Buy |
1,785
+854
| +92% | +$81.3K | ﹤0.01% | 1599 |
|
2020
Q1 | $84K | Sell |
931
-969
| -51% | -$87.4K | ﹤0.01% | 1683 |
|
2019
Q4 | $101K | Buy |
+1,900
| New | +$101K | ﹤0.01% | 1776 |
|
2018
Q4 | – | Sell |
-100
| Closed | -$6K | – | 2391 |
|
2018
Q3 | $6K | Sell |
100
-700
| -88% | -$42K | ﹤0.01% | 2056 |
|
2018
Q2 | $39K | Buy |
+800
| New | +$39K | ﹤0.01% | 1982 |
|